Status:
NOT_YET_RECRUITING
Comprehensive Program for Hereditary Transthyretin Amyloidosis
Lead Sponsor:
Hospital de Alta Complejidad en Red
Conditions:
Amyloidosis in Transthyretin (TTR)
Amyloidosis, Familial
Eligibility:
All Genders
18+ years
Brief Summary
The Comprehensive Program for Hereditary Transthyretin Amyloidosis describes a prospective observational study focused on understanding hereditary transthyretin amyloidosis (ATTR), a progressive and p...
Eligibility Criteria
Inclusion
- Participants with a pathogenic variant of the TTR gene (Hereditary Amyloidosis)
Exclusion
- wild-type TTR amyloidosis
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07213297
Start Date
October 1 2025
End Date
December 1 2028
Last Update
October 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Cuenca Alta de Cañuelas
Cañuelas, Buenos Aires, Argentina, 1814